The MiniMed continuous glucosemonitoring system (CGMS) may havean advantage over self-monitoring ofblood glucose (SMBG) when it comes torevealing daily glucose trends, accordingto Texas researchers.
Ten type 1 children under the ageof 6 who were on twice-daily insulininjection therapy used the MiniMedCGMS for this study. The CGMS detectedtwice as many low blood glucoseepisodes compared with SMBG.
High blood glucose occurred 64percent of the time and hypoglycemiaaccounted for 7 percent of the timemonitored, with nighttime episodes oflow blood glucose lasting longer thandaytime hypoglycemia. Blood glucoselevels in the normal range occurred 24percent of the time. CGMS correlatedwell with SMBG findings. CGMS was welltolerated by the patients.
Twice-daily insulin injection therapywas found inadequate for controllingblood glucose of preschool childrenwith type 1.
—Diabetes Care, February 2005